Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab Maintenance Versus no Maintenance After Stop of First-line Chemotherapy in Patients With Metastatic Colorectal Cancer. A Randomized Multicenter Phase III Non-inferiority Trial

NCT00544700 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT00544700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00544700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab Maintenance Versus no Maintenance After Stop of First-line Chemotherapy in Patients With Metastatic Colorectal Cancer. A Randomized Multicenter Phase III Non-inferiority Trial
Lead sponsor
Swiss Cancer Institute
Phase
Phase 3
Overall status
Terminated
Start date
November 26, 2007
Completion date
December 12, 2019
Enrollment
265 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer